Healthy women with a history of preeclampsia demonstrate an exaggerated vasoconstrictor sensitivity to ang II, due in part to reduced AT2R-mediated dilation and elevations in circulating AT1-AA, which likely contributes to the significantly enhanced risk of CVD morbidity and mortality in these women. This evidence concerns the gene AGT and preeclampsia.